Transforming FVIII Product Classification: AUC and TTR as Game-Changing Metrics for Next-Generation Hemophilia A Therapy
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, has recently shared a very informative post on X:
‘‘Novel FVIII Classification: Scientific Framework for Next-Generation Haemophilia Treatment. Two pharmacokinetic metrics that can redefine how we classify Factor VIII products, presented by Professor Cedric Hermans at ISTH SSC FVIII/FIX session.
The Scientific Challenge
Traditional “standard” vs “extended” half-life classifications have proven inadequate for new generation FVIII products. Recent advances have led to improved ability to maintain FVIII levels within normal range.
New Classification Metrics
– Area Under the Curve (AUC) > 40%
Measures total drug exposure over time, providing comprehensive assessment of sustained FVIII activity rather than peak-focused measurements
– Time in Target Range (TTR) > 40%
Evaluates percentage of time patients maintain therapeutically effective FVIII levels, offering crucial insights into sustained haemostatic protection
Comparative Performance Data
– Standard Half-Life (SHL-FVIII): Baseline comparators (AUC ratio: 1, TTR ratio: 1)
– Extended Half-Life (EHL-FVIII): 4-5x AUC improvement, 2x TTR enhancement
– Ultra-Long/High Sustained Activity (UL/HSA-FVIII): 40x AUC improvement, 4x TTR boost
Products like efanesoctocog alfa demonstrate remarkable sustained activity, maintaining mean FVIII levels >40 IU/dL for 4 days with geometric mean half-life of 43.3 hours
Future Integration
Further validation can be warranted for integration into routine clinical evaluation and PK tools like WAPPS-Hemo, MyPKFit, and Florio. These platforms enable Bayesian forecasting of individual PK profiles for personalized treatment optimization.
As the field evolves toward normal hemostasis as the treatment goal, these metrics provide an important scientific basis for evaluating innovative therapies.”
Stay updated with Hemostasis Today.
-
Aug 26, 2025, 10:02Women’s Equality Day: HFA Recognizes Women with Bleeding Disorders
-
Aug 26, 2025, 09:59Rare Disease Advisor – RBC Rheology Alterations in Hemophilia with Arthropathy
-
Aug 26, 2025, 09:57HFA Supports Future Planning for People with Bleeding Disorders
-
Aug 26, 2025, 09:56Phillip Taboada: TXA Shows No Added Benefit in Aquablation
-
Aug 26, 2025, 09:50A Global Collaboration: PERT Consortium Expands Reach in PE Care
-
Aug 26, 2025, 09:54TSUBASA Study: Emicizumab Improves Daily Life and Motivation in Hemophilia A Patients
-
Aug 26, 2025, 09:38Advancing CAT Care: New Insights on Extended Anticoagulation from Gerotziafas and Tafur
-
Aug 26, 2025, 09:35Alexander Mazein: Innovative Insights into Cytokine Release Syndrome via a Novel Explorable Model for Biotherapeutics and Cellular Therapies
-
Aug 25, 2025, 10:40Maria Filomena Ruberto on The Hypercoagulable State
-
Aug 25, 2025, 09:19Parham Dastjerdi – Clonal Hematopoiesis and VTE Risk
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 26, 2025, 09:42David McIntosh Highlights Global Blood Shortages and Fresh vs Stored RBCs
-
Aug 23, 2025, 07:48Protecting Heart and Brain Health: Stroke Prevention in Women with Bleeding Disorders: NBDF
-
Aug 21, 2025, 15:08Global Variations in Blood Collection: What Explains the Differences?
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!